Announcements Trials

Browse Landscape

Phase

Phase NA 2 Phase 3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 9 Genitourinary 5 Thoracic 3 Plasma cell 3 Head & Neck 3 Gastrointestinal 3 Lymphoid 2 Tumor-Agnostic 1 Other neoplasm 1 Other hematologic neoplasm 1 Other 1 Gynecologic 1 Dermatologic 1

Conditions

Hematologic Diseases 1 Dyspnea 1

Interventions

Radiotherapy 5 Surveys and Questionnaires 4 Cisplatin 4 angiotensin I (1-7) 3 alvimopan 3 Radiation 3 Injections 3 Water 2 Vitamin D 2 Tirzepatide 2 RRx-001 2 Mouthwashes 2 Metformin 2 Interleukin 1 Receptor Antagonist Protein 2 High-Intensity Focused Ultrasound Ablation 2 Drug Therapy 2 Dexmedetomidine 2 Dexamethasone 2 Calcium Dobesilate 2 Amifostine 2 Acetylcysteine 2 tempol 1 peppermint oil 1 pegfilgrastim 1 naloxegol 1 methylnaltrexone 1 methyl N-acetylsibirosaminide 1 linaclotide 1 licogliflozin 1 kang-lai-te 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Sugars × Other × Clear all

NCT01670097 2021-02-17

Dexamethasone Dyspnea Study

M.D. Anderson Cancer Center

Phase 2 Completed

52 enrolled 13 charts

Dyspnea, Hematologic Diseases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡